About: Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.97 (+0.67%)
XLONASDAQXilio Development Inc
Xilio Development Inc share price
XLO price activity
Last Price
$8.970
Change (24hr)
0.06 USD (0.67%)
Volume
8.82K
Volume (4w avg)
-
Open
$8.91
Day Range
$8.80 - $9.00
Previous Close
$8.91
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
XLO price performance
Delayed
09 Sep, 8:00 pm GMT+0
XLO Market Signals